
Sign up to save your podcasts
Or
Tania De Jong, Executive Director and Founder of Mind Medicine Australia, talks about the TGA Announcement the Delegate's Final Decision to Reschedule the Use of Psilocybin and MDMA for Medical Purposes for conditions such as treatment resistant depression.
Find out more here: Mind Medicine Australia
See omnystudio.com/listener for privacy information.
Tania De Jong, Executive Director and Founder of Mind Medicine Australia, talks about the TGA Announcement the Delegate's Final Decision to Reschedule the Use of Psilocybin and MDMA for Medical Purposes for conditions such as treatment resistant depression.
Find out more here: Mind Medicine Australia
See omnystudio.com/listener for privacy information.
838 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners